OBJECTIVES This study examined the relationship between income inequality and heart failure outcomes.
H eart failure (HF) is now recognized as a major public health problem not only in Western nations but also in low-and middleincome countries, reflecting the demographic changes and the epidemiological transition to noncommunicable diseases occurring in the latter countries (1) . The growing recognition of the international importance of HF has been accompanied by studies highlighting the considerable differences in HF outcomes that exist among countries (2, 3) . Understanding the basis of these differences may help in tackling this increasing global problem.
Some of the geographical variations in identified outcomes are attributable to differences in recognized prognostic factors such age, HF severity, and comorbidity. Other factors may also be pertinent, such as income inequality, which varies considerably internationally and is often particularly marked in low-and middle-income countries. The income inequality hypothesis postulates that population health is influenced by the degree to which income is unevenly distributed within a society (4, 5) . This hypothesis was developed to explain why large differences in population health are still observed in developed countries with high levels of income, as measured by gross domestic product (GDP) per capita (6, 7) . A variety of studies has shown a negative correlation between income inequality and life expectancy, infant mortality, and the incidence, Failure) trials were 2 of the largest clinical trials in patients with HF with reduced ejection fraction (HFrEF) (8, 9) . The present study analyzed a pooled cohort of 15,216 participants from 54 of the 55 countries worldwide who were enrolled in the 2 trials to examine the potential association among different levels of income inequality and clinical characteristics and outcomes in patients with HFrEF.
METHODS TRIALS AND PARTICIPANTS. The design, baseline characteristics, and outcomes of the PARADIGM-HF and ATMOSPHERE trials have been published and are briefly described here (8, 9) . The inclusion and (8, 9) .
STUDY GROUPS. The impact of income inequality was evaluated using the Gini coefficient, which is derived from the Lorenz curve (Online Figure S1 ), in which 0 (0%) indicates absolute income equality and Income Inequality and Outcomes in Heart Failure Income Inequality and Outcomes in Heart Failure Values are n (%), median (IQR), or mean AE SD. Events are reported as n (%) and as rate per 100 patient-years (95% CI). Primary outcome was tested for competing risk of all non-CV death; first hospitalization for HF was tested for competing risk of all-cause death; and CV death was tested for competing risk of all non-CV death. All models were adjusted for region and randomized treatment at baseline. *Adjusted for age, sex, HR, SBP, BMI, NT-proBNP, eGFR, LVEF, and NYHA functional class. †Adjusted for age, sex, HR, SBP, BMI, NT-proBNP, eGFR, LVEF, NYHA functional class, per capita income, education index, hospital bed density, and health worker density. Table 1 . Figure 2 ). This trend was also observed for both of the rates of cardiovascular and all-cause death, which were highest in tertile 3 patients (8.9 and 10.4, respectively) and lowest in tertile 1 patients (5.9 and 7.4, respectively) (Table 2, Figure 2 ).
CI ¼ confidence interval; CV ¼ cardiovascular; other abbreviations as in
In the model that was adjusted for conventional prognostic variables, including NT-proBNP, patients in Gini tertile 3 remained at significantly higher risk of the primary composite outcome (57% higher risk) and of cardiovascular and all-cause death (55% and 48% higher, respectively) ( Table 2) .
When country per capita income, education index, hospital bed density, and health worker density were added to the multivariate models, the elevated risk in Gini tertile 3 patients was attenuated but remained significant (46%, 35%, and 30% higher for the primary composite outcome, cardiovascular death, and allcause mortality, respectively) ( Table 2) . When the Gini coefficient was considered a continuous rather than a categorical variable, it remained an independent predictor of outcomes. Each 10-point increase in
Gini coefficient was associated with a higher risk of 
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A P R I L 2 0 1 9 : Table S2 , Figure 3 ). As seen in Figure 3 , the impact of a 10-point increase in Gini coefficient on cardiovascular death was greater than that of most other predictive variables, including advancing age and previous MI. Gini coefficient predicted a 1% higher probability of dying from CHD (19) . The present study extended this The baseline characteristics, medical history, and background treatment of patients differed markedly according to income inequality but perhaps not predictably or intuitively, given the association between higher Gini coefficient and worse outcomes.
For example, patients in countries with the highest Gini coefficient (tertile 3; greatest income inequality)
were, on average, 5 years younger than those in the lowest tertile countries, and they were more often women who had less comorbidity, had an ischemic cause less often, had HF more recently diagnosed, had a better NYHA functional class profile and Kansas City Cardiomyopathy Questionnaire score, and had the highest mean eGFR. These are all features that were expected to track with better rather than worse outcomes, which could be attributable to the fact that patients in Gini tertile 3 were younger (20) . Indeed, only a few variables associated with a poor prognosis were more unfavorable in the Gini coefficient tertile 3 patients, including an average LVEF that was lower (À1.9%) in tertile 3 patients than in tertile 1 patients, as was SBP (À5.2 mm Hg),
whereas median NT-proBNP levels were somewhat higher (þ142 pg/ml). There were also some treatment differences among the groups that were more expected, for example, digoxin (which is inexpensive) was used most often in tertile 3 patients,
whereas devices (which are more expensive) were used much less often.
Even after correcting for patient-level biological characteristics known to predict outcomes, including the most powerful of these, NT-proBNP, patients in Gini tertile 3 had considerably higher mortality than those in tertile 1. Indeed, the adjusted HR was 1.48 willingness of societies to invest in social services and welfare programs, broad access to health care services, and safety nets (24, 25) . These effects may lead to distortions of health care priorities and spending and can be exacerbated by geographical concentrations of hospitals and physicians in more affluent areas, with provision of medically unnecessary services and performance of discretionary procedures in these areas.
Conversely, there may be underinvestment in health care infrastructure and resources in areas of greater need, with reduced access to and affordability of health care for the neediest (25 Some of these societal issues may also be greater in low-and middle-income countries undergoing epidemiologic transitions from infectious diseases to noncommunicable diseases (27) . Here, health strategies and policies need to change, but these countries often display a high level of income disparity, despite (or because of) accelerated economic growth in many cases (28) .
Among the psychosocial explanations, the one that is of most interest in HF is the belief that chronic stress as a consequence of the income inequality described above has detrimental psychoneuroendocrine effects (18) . There is long-standing evidence that stress may be involved in at least some types of CVDs. For example, in the INTERHEART study, Rosengren et al. (29) found that psychosocial stressors were associated with a higher risk of acute MI. Chronic stress is associated with memory impairment, anxiety, and depression, all of which are common in HF and potentially harmful because of adverse effects on adherence and self-management (30, 31) . Moreover, recent evidence has suggested even more widespread biological consequences of stress including reduced immune responses and impaired endothelial function (32) .
STUDY STRENGTHS AND LIMITATIONS. To the best of the present authors' knowledge, the current study is the first to investigate the association between income inequality and outcomes in HF (or any chronic disease) transnationally. However, the present study is based on a highly selected clinical trial population recruited from specific centers and may not necessarily represent the general population.
Not all the countries in this analysis were from similar income categories, and information on individual socioeconomic status was missing, but adjustment was made for per capita income representing population-level income for each country.
Accordingly, differences in health care systems were not adjusted because most of the countries did not follow any particular health care system (33) . An attempt was made to make up for those shortcomings Income Inequality and Outcomes in Heart Failure
